Heparin specifically inhibits binding of apolipoprotein E to amyloid β-peptide
Authors:
- 1 February 2000
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 280 (2) , 131-134
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Apolipoprotein ECurrent Opinion in Lipidology, 1999
- Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril StabilityJournal of Neurochemistry, 1997
- The Interaction between Apolipoprotein E and Alzheimer's Amyloid β-Peptide Is Dependent on β-Peptide ConformationJournal of Biological Chemistry, 1996
- Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and LJournal of Biological Chemistry, 1995
- Characterization of Apolipoprotein J-Alzheimer's Aβ InteractionJournal of Biological Chemistry, 1995
- pH‐Dependent Binding of Synthetic β‐Amyloid Peptides to GlycosaminoglycansJournal of Neurochemistry, 1993
- Chondroitin Sulfate Proteoglycans Are Associated with the Lesions of Alzheimer's DiseaseExperimental Neurology, 1993
- Biospecific interaction analysis using biosensor technologyNature, 1993
- [28] Molecular design and modeling of protein—heparin interactions1991
- Affinity chromatography on heparin-sepharose under reducing conditions as a method of selective enrichment with individual isoforms of apolipoprotein EBulletin of Experimental Biology and Medicine, 1990